MA53544A - Procédé de préparation de compositions de vaccin - Google Patents

Procédé de préparation de compositions de vaccin

Info

Publication number
MA53544A
MA53544A MA053544A MA53544A MA53544A MA 53544 A MA53544 A MA 53544A MA 053544 A MA053544 A MA 053544A MA 53544 A MA53544 A MA 53544A MA 53544 A MA53544 A MA 53544A
Authority
MA
Morocco
Prior art keywords
vaccine compositions
preparing vaccine
preparing
compositions
vaccine
Prior art date
Application number
MA053544A
Other languages
English (en)
Inventor
Zsolt Csiszovszki
Julianna Liszewicz
Orsolya Lorincz
Mónika Megyesi
Levente Molnár
Péter Páles
Katalin Pántya
Eszter Somogyi
Eniko Toke
József Toth
Original Assignee
Treos Bio Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Treos Bio Ltd filed Critical Treos Bio Ltd
Publication of MA53544A publication Critical patent/MA53544A/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4748—Tumour specific antigens; Tumour rejection antigen precursors [TRAP], e.g. MAGE
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/0005—Vertebrate antigens
    • A61K39/0011—Cancer antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/0005—Vertebrate antigens
    • A61K39/0011—Cancer antigens
    • A61K39/001102—Receptors, cell surface antigens or cell surface determinants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70503—Immunoglobulin superfamily
    • C07K14/70539—MHC-molecules, e.g. HLA-molecules
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2803—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the immunoglobulin superfamily
    • C07K16/2818—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the immunoglobulin superfamily against CD28 or CD152
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2803—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the immunoglobulin superfamily
    • C07K16/2827—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the immunoglobulin superfamily against B7 molecules, e.g. CD80, CD86
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6881—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for tissue or cell typing, e.g. human leukocyte antigen [HLA] probes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55505—Inorganic adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55566—Emulsions, e.g. Freund's adjuvant, MF59
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55572—Lipopolysaccharides; Lipid A; Monophosphoryl lipid A
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55577—Saponins; Quil A; QS21; ISCOMS

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Microbiology (AREA)
  • Zoology (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Cell Biology (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Analytical Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Engineering & Computer Science (AREA)
  • Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
MA053544A 2018-09-04 2019-09-03 Procédé de préparation de compositions de vaccin MA53544A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB1814362.8A GB201814362D0 (en) 2018-09-04 2018-09-04 Composition and process for preparing vaccine

Publications (1)

Publication Number Publication Date
MA53544A true MA53544A (fr) 2021-07-14

Family

ID=63920945

Family Applications (1)

Application Number Title Priority Date Filing Date
MA053544A MA53544A (fr) 2018-09-04 2019-09-03 Procédé de préparation de compositions de vaccin

Country Status (17)

Country Link
US (3) US20200069786A1 (fr)
EP (1) EP3847185A1 (fr)
JP (2) JP2021535749A (fr)
KR (1) KR20210086610A (fr)
CN (1) CN113383009A (fr)
AU (1) AU2019334261B2 (fr)
BR (1) BR112021004075A2 (fr)
CA (1) CA3110923A1 (fr)
CL (1) CL2021000534A1 (fr)
CO (1) CO2021004028A2 (fr)
EA (1) EA202190669A1 (fr)
GB (1) GB201814362D0 (fr)
IL (1) IL281220A (fr)
MA (1) MA53544A (fr)
MX (1) MX2021002543A (fr)
SG (1) SG11202101881UA (fr)
WO (1) WO2020048995A1 (fr)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA3054861A1 (fr) 2017-03-03 2018-09-07 Treos Bio Zrt Vaccins peptidiques
GB201804468D0 (en) * 2018-03-21 2018-05-02 Valo Therapeutics Oy PeptiCRAd Cancer Therapy
TW202016131A (zh) * 2018-05-16 2020-05-01 德商英麥提克生物技術股份有限公司 用於抗癌免疫治療的肽
MA53543A (fr) 2018-09-04 2021-07-14 Treos Bio Ltd Vaccins peptidiques
KR20220038776A (ko) * 2019-07-30 2022-03-29 유니버시티 헬스 네트워크 T 세포 수용체 및 이의 사용 방법
GB202004974D0 (en) 2020-04-03 2020-05-20 Treos Bio Ltd Coronavirus vaccine
CN116406472A (zh) * 2020-04-20 2023-07-07 Nec奥克尔姆内特公司 用于鉴定经预测以激发免疫原性响应的一种或多种源蛋白的一个或多个候选区的方法和系统以及用于产生疫苗的方法
WO2021243295A2 (fr) * 2020-05-29 2021-12-02 Children's National Medical Center Identification d'épitopes peptidiques de prame restreints par hla, lymphocytes t spécifiques de prame appropriés pour le traitement standard d'un cancer exprimant prame
CN111617238B (zh) * 2020-06-02 2022-12-13 苏州药明康德新药开发有限公司 小鼠ct26结直肠癌治疗性肿瘤多肽疫苗制剂及其制备方法
EP3945320A1 (fr) * 2020-07-29 2022-02-02 Corporació Sanitària Parc Taulí Épitope amélioré pour la détection et/ou la quantification des auto-anticorps contre l'alpha-fétoprotéine
US20240228536A1 (en) * 2020-10-28 2024-07-11 Follicum Ab Peptides for use in skin and hair pigmentation
BR112023021162A2 (pt) * 2021-04-14 2024-01-16 Academisch Ziekenhuis Leiden Peptídeos imunogênicos de magec2, proteínas de ligação que reconhecem os peptídeos imunogênicos de magec2 e usos dos mesmos
CN113144181B (zh) * 2021-04-20 2022-07-19 徐州医科大学 一种靶向b7h3的dna疫苗、制备方法及应用
CN114195861A (zh) * 2022-01-05 2022-03-18 许昌学院 亲和肽
CN115785204B (zh) * 2022-06-10 2024-02-13 河北博海生物工程开发有限公司 肺癌特异性分子靶标08及其用途
CN115785211B (zh) * 2022-06-10 2024-09-24 河北博海生物工程开发有限公司 肺癌特异性分子靶标04及其用途
CN118909138A (zh) * 2024-04-29 2024-11-08 北京臻知医学科技有限责任公司 一种肿瘤疫苗及其应用

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4235877A (en) 1979-06-27 1980-11-25 Merck & Co., Inc. Liposome particle containing viral or bacterial antigenic subunit
FR2791895B1 (fr) 1999-03-23 2001-06-15 Pasteur Merieux Serums Vacc Utilisation de trehalose pour stabiliser un vaccin liquide
AUPQ776100A0 (en) * 2000-05-26 2000-06-15 Australian National University, The Synthetic molecules and uses therefor
GB0520067D0 (en) * 2005-10-01 2005-11-09 Cancer Rec Tech Ltd Treatment of cancer
EP2089423B1 (fr) * 2006-09-21 2016-10-26 Vaxil Biotherapeutics Ltd. Vaccins à multiples épitopes spécifiques à un antigène
GB201004575D0 (en) * 2010-03-19 2010-05-05 Immatics Biotechnologies Gmbh Composition of tumor associated peptides and related anti cancer vaccine for the treatment of gastric cancer and other cancers
WO2012051282A2 (fr) * 2010-10-14 2012-04-19 The Ohio State University Research Foundation Diagnostic et thérapie du cancer ciblés sur des protéines de type piwil2 (pl2l)
GB201315946D0 (en) * 2013-09-06 2013-10-23 Immune Targeting Systems Its Ltd Oncology vaccine
CA3054861A1 (fr) * 2017-03-03 2018-09-07 Treos Bio Zrt Vaccins peptidiques
EP3370065A1 (fr) 2017-03-03 2018-09-05 Treos Bio Kft Peptides immunogènes
EP3369431A1 (fr) 2017-03-03 2018-09-05 Treos Bio Kft Vaccin

Also Published As

Publication number Publication date
JP2021535749A (ja) 2021-12-23
KR20210086610A (ko) 2021-07-08
CA3110923A1 (fr) 2020-03-12
EP3847185A1 (fr) 2021-07-14
JP2025069437A (ja) 2025-04-30
GB201814362D0 (en) 2018-10-17
US20200069786A1 (en) 2020-03-05
BR112021004075A2 (pt) 2021-05-25
US20210236611A1 (en) 2021-08-05
AU2019334261A1 (en) 2021-03-18
WO2020048995A1 (fr) 2020-03-12
SG11202101881UA (en) 2021-03-30
US20220160854A1 (en) 2022-05-26
CN113383009A (zh) 2021-09-10
EA202190669A1 (ru) 2021-06-03
CO2021004028A2 (es) 2021-06-21
MX2021002543A (es) 2021-08-11
IL281220A (en) 2021-04-29
AU2019334261B2 (en) 2025-04-10
CL2021000534A1 (es) 2021-09-24

Similar Documents

Publication Publication Date Title
MA53544A (fr) Procédé de préparation de compositions de vaccin
EP4135764A4 (fr) Compositions de vaccin pan-coronavirus multi-épitope
MA54253A (fr) Procédé de préparation de dérivés de 2-chloro-4-hétéroaryl-pyridimidines
EP3012322A4 (fr) Souche de délétion de gène de virus de pseudo-rage porcine, composition de vaccin et son procédé de préparation et application associée
EP3347043C0 (fr) Procédé de préparation d'un vaccin atténué tétravalent contre la dengue
MA54396A (fr) Procédé de préparation de n-phénylpyrazole-1-carboxamides
EP3360531A4 (fr) Préparation en kit et procédé de réglage de dose
EP3766869A4 (fr) Procédé simple de préparation d'avibactam
EP3597674A4 (fr) Procédé de préparation de copolymère
EP3730620A4 (fr) Vaccin antigénique à immunisation croisée et son procédé de préparation
EP3400197A4 (fr) Procédé améliore de préparation de bleu isosulfane
EP3539941A4 (fr) Procédé de préparation triméthylolpropane
EP3344293A4 (fr) Compositions de vaccin stabilisés de vlp
EP3966270A4 (fr) Procédé de préparation de polyorganosiloxanes
MA53346A (fr) Composition de vaccin muqueux pour la mastite bovine
EP3505525A4 (fr) Procédé de préparation de rubusoside
SG11202109566XA (en) Method for preparing influenza ha split vaccine
EP3444253A4 (fr) Procédé de préparation de ad-35
EP3455210A4 (fr) Procédé de préparation de boscalide
EP3816249A4 (fr) Composition adhésive et son procédé de préparation
EP3733651A4 (fr) Procédé de préparation de calcobutrol
EP3365332A4 (fr) Procédé de préparation d'intermédiaire pour dérivé d'oxazolidinone
EP3889165A4 (fr) Composition de vaccin antirabique et son procédé de préparation
EP3865556A4 (fr) Procédé de préparation de points quantiques
EP3436439A4 (fr) Procédé de préparation de dérivés de diphénylpyrazine